Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1980-09-11
1982-03-02
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
435235, 435239, A61K 39245
Patent
active
043178111
ABSTRACT:
A herpes simplex type 1 subunit vaccine is prepared from infected chick embryo cells by urea-extraction of the virus while the infected cells are still attached to the growth surface.
REFERENCES:
Tumilowicz et al. J. Med. Virol. (1978) 3(2): 151-156.
Zechel Eur. J. Biochem. (1977) 77(1): 133-139.
Denys, Med. Dosw. Mikrobiol. (1970) 22(3): 243-248.
Sitnikov et al. VOP. Virusol. (1968) 13(5): 554-560.
Farrah Canad J. Microbiol. (1979) 25(9): 145-151.
Powell et al. Nature 249, May 24, 1974: 360-361.
Kitces et al. Infection and Immunity Jun. 1977: 955-960.
C.A. 70:17,866e (1969).
C.A. 74:108,598t (1971).
C.A. 76:139,079v (1972).
C.A. 80:19,527a (1974).
C.A. 87:80,353b (1977).
C.A. 90:97,989y (1979).
C.A. 90:109,946x (1979).
Bertland Alexander U.
Lampson George P.
Merck & Co. , Inc.
Perrella Donald J.
Pfeiffer Hesna
Rose Shep K.
LandOfFree
Herpes simplex type 1 subunit vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Herpes simplex type 1 subunit vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Herpes simplex type 1 subunit vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-59538